Kinetics of the interaction of nonsteroidal antiinflammatory drugs with prostaglandin endoperoxide synthase-1 studied by limited proteolysis

被引:43
作者
Kalgutkar, AS
Crews, BC
Marnett, LJ
机构
[1] VANDERBILT UNIV, SCH MED, MEM LAB CANC RES, DEPT BIOCHEM, NASHVILLE, TN 37232 USA
[2] VANDERBILT UNIV, SCH MED, MEM LAB CANC RES, DEPT CHEM, NASHVILLE, TN 37232 USA
关键词
D O I
10.1021/bi9605752
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Many nonsteroidal antiinflammatory agents (NSAIDs) bind to prostaglandin endoperoxide synthase (PGHS) and induce a conformational change in the PGHS apoprotein that renders it resistant to cleavage by trypsin at Arg(277). In the present study, the trypsin protection assay was modified to permit detection of conformational changes at times as short as 5 s after the addition of inhibitor. The kinetics of the induction and reversal of trypsin resistance in apoPGHS-1 by a series of NSAIDs and isozyme- specific PGHS-1 and PGHS-2 inhibitors were determined. All compounds induced resistance to trypsin cleavage at a rapid rate, The conformational change induced by competitive inhibitors was reversed on prolonged incubation with trypsin (similar to 5 min). In contrast, the resistance induced by irreversible inhibitors was not lost during a 5 min incubation with trypsin. All of the selective PGHS-2 inhibitors protected against tryptic cleavage of apoPGHS-1 but did not inhibit the protein's cyclooxygenase activity. The results suggest that induction of trypsin resistance is a reflection of the initial association of reversible as well as irreversible inhibitors with the apoprotein.
引用
收藏
页码:9076 / 9082
页数:7
相关论文
共 28 条
[1]   CHARACTERIZATION OF INDUCIBLE CYCLOOXYGENASE IN RAT-BRAIN [J].
BREDER, CD ;
DEWITT, D ;
KRAIG, RP .
JOURNAL OF COMPARATIVE NEUROLOGY, 1995, 355 (02) :296-315
[2]  
CHEN YNP, 1987, J BIOL CHEM, V262, P16892
[3]   MECHANISM OF SELECTIVE-INHIBITION OF THE INDUCIBLE ISOFORM OF PROSTAGLANDIN G/H SYNTHASE [J].
COPELAND, RA ;
WILLIAMS, JM ;
GIANNARAS, J ;
NURNBERG, S ;
COVINGTON, M ;
PINTO, D ;
PICK, S ;
TRZASKOS, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (23) :11202-11206
[4]   RENAL ABNORMALITIES AND AN ALTERED INFLAMMATORY RESPONSE IN MICE LACKING CYCLOOXYGENASE-II [J].
DINCHUK, JE ;
CAR, BD ;
FOCHT, RJ ;
JOHNSTON, JJ ;
JAFFEE, BD ;
COVINGTON, MB ;
CONTEL, NR ;
ENG, VM ;
COLLINS, RJ ;
CZERNIAK, PM ;
GORRY, SA ;
TRZASKOS, JM .
NATURE, 1995, 378 (6555) :406-409
[5]   HYPERALGESIC EFFECTS OF PROSTACYCLIN AND PROSTAGLANDIN-E2 [J].
FERREIRA, SH ;
NAKAMURA, M ;
CASTRO, MSDA .
PROSTAGLANDINS, 1978, 16 (01) :31-37
[6]   NS-398, A NEW ANTIINFLAMMATORY AGENT, SELECTIVELY INHIBITS PROSTAGLANDIN-G/H SYNTHASE CYCLOOXYGENASE (COX-2) ACTIVITY IN-VITRO [J].
FUTAKI, N ;
TAKAHASHI, S ;
YOKOYAMA, M ;
ARAI, I ;
HIGUCHI, S ;
OTOMO, S .
PROSTAGLANDINS, 1994, 47 (01) :55-59
[7]   9,11-EPOXY-9-HOMO-14-OXAPROSTA-5-ENOIC ACID-DERIVATIVES - NOVEL INHIBITORS OF FATTY-ACID CYCLOOXYGENASE [J].
HALL, SE ;
HAN, WC ;
HASLANGER, MF ;
HARRIS, DN ;
OGLETREE, ML .
JOURNAL OF MEDICINAL CHEMISTRY, 1986, 29 (11) :2335-2347
[8]   INHIBITION OF PROSTAGLANDIN BIOSYNTHESIS BY SQ-28,852, A 7-OXABICYCLO-[2.2.1]HEPTANE ANALOG [J].
HARRIS, DN ;
PHILLIPS, MB ;
MICHEL, IM ;
GOLDENBERG, HJ ;
STEINBACHER, TE ;
OGLETREE, ML ;
HALL, SE .
PROSTAGLANDINS, 1986, 31 (04) :651-667
[9]  
KUJUBU DA, 1991, J BIOL CHEM, V266, P12866
[10]  
KULMACZ RJ, 1989, J BIOL CHEM, V264, P14136